Načítá se...
P08.28 The combination therapy with temozolomide and DWMA-003TS for glioblastoma in vitro and invivo experiments
Introduction: Glioblastoma (GBM) is the most frequent primary malignant brain tumor in adults. Although GBM patients received aggressive treatment, their median survival was less than 14.6 months. It is important to find a new regimen to prolong the survival. The purpose of present study was to inve...
Uloženo v:
| Vydáno v: | Neuro Oncol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5463883/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox036.218 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|